Eribulin Mesylate Improves Cisplatin-Induced Cytotoxicity of Triple-Negative Breast Cancer by Extracellular Signal-Regulated Kinase 1/2 Activation

Background and Objectives; Triple-negative breast cancer (TNBC) is associated with poor patient prognosis because of its multiple molecular features. Thus, more effective treatment for TNBC is urgently needed. This study determined the possible involvement of ERK1/2 activation in cisplatin-induced c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Hyemi, Lee, Myungsun, Cha, Eunyoung, Sul, Jiyoung, Park, Junbeom, Lee, Jinsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025504/
https://www.ncbi.nlm.nih.gov/pubmed/35454385
http://dx.doi.org/10.3390/medicina58040547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025504/
https://www.ncbi.nlm.nih.gov/pubmed/35454385
http://dx.doi.org/10.3390/medicina58040547

Ejemplares similares